Peri-implant evaluation of immediately loaded implants placed in esthetic zone in patients with diabetes mellitus type 2: a two-year study
Objectives The aim of this study was to evaluate implant survival and primary stability parameters in patients with diabetes with different levels of glycosylated hemoglobin Alc (HbA1c) treated with immediate placement and provisionalization of implant‐supported, single‐tooth replacements over 2 yea...
Saved in:
Published in | Clinical oral implants research Vol. 27; no. 2; pp. 156 - 161 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Blackwell Publishing Ltd
01.02.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives
The aim of this study was to evaluate implant survival and primary stability parameters in patients with diabetes with different levels of glycosylated hemoglobin Alc (HbA1c) treated with immediate placement and provisionalization of implant‐supported, single‐tooth replacements over 2 years.
Materials and methods
Eighty‐five patients were divided into three groups according to their HbA1c levels: 33 patients in Group 1 (<6, control group); 30 patients in Group 2 (6.1–8); and 22 patients in Group 3 (8.1–10). Each patient received one‐one‐piece implant in the anterior zone of the upper maxillary. The implant survival rate was analyzed for each group, together with three variables to evaluate the general state of peri‐implant health: probe depth, bleeding on probing, marginal bone loss.
Results
Marginal bone loss increased in relation with higher HbA1c levels. For marginal bone loss in Group 1, mean resorption values ranged from 0.51 after 6 months to 0.72 after 2 years in comparison with respective values of 1.33 and 1.92 in Group 3. This pattern was repeated for bleeding on probing, both parameters showing significant differences between groups. For bleeding on probing, mean bleeding levels varied from 0.36 in Group I at 6 months after implant placement, to 0.59 in Group 3 (P = 0.041 between the three groups). Peri‐implant pocket depth showed the same tendency to increase in relation to HbA1C but differences between groups did not reach statistical significance.
Conclusions
Patients with diabetes can receive implant‐based treatments with immediate loading safely, providing they present moderate HbA1c values. |
---|---|
Bibliography: | ark:/67375/WNG-J65X13ZM-T istex:2A53BBB9A627A78C5CBD255E69A5573FF24878F4 ArticleID:CLR12552 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0905-7161 1600-0501 |
DOI: | 10.1111/clr.12552 |